Arrowhead Pharmaceuticals, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 73.7M | 264.0M | 256.5M | 27.8M | 542.7M | 2.5M | 0 | 0 |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 5.0M | 4.8M |
| Gross Profit | 73.7M | 264.0M | 256.5M | 27.8M | 542.7M | 2.5M | -5.0M | -4.8M |
| R&D Expenses | 173.3M | 177.2M | 174.7M | 162.4M | 133.1M | 137.0M | 131.4M | 148.2M |
| Operating Expenses | 215.0M | 223.2M | 212.4M | 193.3M | 161.5M | 163.9M | 157.2M | 171.4M |
| Operating Income | -141.3M | 40.8M | 44.1M | -165.6M | 381.2M | -161.4M | -162.2M | -176.1M |
| Other Income / Gains | 3.7M | -12.5M | -8.0M | -13.5M | -11.6M | -13.7M | -10.6M | 2.2M |
| Net Income | -132.7M | 30.8M | -23.8M | -175.2M | 370.4M | -173.1M | -170.5M | -170.8M |
| EPS (Diluted) | -0.93 | 0.22 | -0.17 | -1.26 | 2.78 | -1.39 | -1.40 | -1.38 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0 | 0 |
| General And Administrative Expenses | 41.2M | 45.5M | 37.2M | 30.4M | 27.9M | 26.4M | 25.8M | 23.2M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 41.2M | 45.5M | 37.2M | 30.4M | 27.9M | 26.4M | 25.8M | 23.2M |
| Other Expenses | 500K | 504K | 503K | 505K | 511K | 509K | 0 | 0 |
| Cost And Expenses | 215.0M | 223.2M | 212.4M | 193.3M | 161.5M | 163.9M | 162.2M | 176.1M |
| Interest Income | 16.9M | 9.7M | 9.1M | 11.0M | 9.6M | 7.6M | 7.2M | 6.5M |
| Interest Expense | 23.8M | 22.5M | 21.7M | 24.4M | 21.6M | 21.6M | 14.6M | 5.1M |
| Depreciation And Amortization | 6.4M | 6.4M | 6.4M | 6.2M | 6.1M | 5.2M | 5.0M | 4.8M |
| Ebitda | -107.4M | 57.2M | 64.2M | -148.5M | 397.3M | -148.2M | -153.1M | -164.1M |
| Ebitdaratio | -1.456 | 0.217 | 0.25 | -5.347 | 0.732 | -59.294 | 0 | 0 |
| Operating Income Ratio | -1.916 | 0.155 | 0.172 | -5.962 | 0.702 | -64.565 | 0 | 0 |
| Income Before Tax | -137.6M | 28.3M | 36.1M | -179.1M | 369.6M | -175.1M | -172.8M | -174.0M |
| Income Before Tax Ratio | -1.866 | 0.107 | 0.141 | -6.45 | 0.681 | -70.046 | 0 | 0 |
| Income Tax Expense | 7K | 29K | 20.0M | -437K | 1.8M | 103K | 546K | 0 |
| Net Income Ratio | -1.80 | 0.117 | -0.093 | -6.311 | 0.683 | -69.234 | 0 | 0 |
| Epsdiluted | -0.93 | 0.22 | -0.17 | -1.26 | 2.75 | -1.39 | -1.40 | -1.38 |
| Weighted Average Shs Out | 142.4M | 140.1M | 135.7M | 139.0M | 133.4M | 124.8M | 122.0M | 124.2M |
| Weighted Average Shs Out Dil | 142.4M | 140.7M | 135.7M | 139.0M | 134.5M | 124.8M | 122.0M | 124.2M |